Literature DB >> 15626225

Effects of treatment with and without adjuvant radiation therapy on recurrence of ocular and adnexal squamous cell carcinoma in horses: 157 cases (1985-2002).

Cory B Mosunic1, Phillip A Moore, K Paige Carmicheal, Matthew J Chandler, Anand Vidyashankar, Ying Zhao, Royce E Roberts, Ursula M Dietrich.   

Abstract

OBJECTIVE: To determine the effects of treatment with and without adjuvant radiation therapy on recurrence of ocular and adnexal squamous cell carcinoma (SCC) at specific anatomic locations in horses.
DESIGN: Retrospective study. ANIMALS: 91 horses. PROCEDURES: Medical records of horses with histologically confirmed ocular and adnexal SCC evaluated from 1985 to 2002 were reviewed. Sex, breed, age, type of treatment, location, and recurrence of SCC were recorded. Two treatment groups determined by recurrence of SCCs treated with and without adjuvant radiation therapy were established.
RESULTS: The anatomic site with the highest recurrence rate was the limbus (junction of the cornea and sclera) or bulbar conjunctiva (477%), independent of treatment group. There was a significant difference in recurrence rates of ocular and adnexal SCCs between the 2 treatment groups, independent of anatomic location. Recurrence rates of SCCs treated with and without adjuvant radiation therapy were 11.9% and 44.1%, respectively. Recurrence rates for SCCs of the eyelid, limbus or bulbar conjunctiva, and cornea treated with adjuvant radiation therapy were significantly different from those for SCCs treated without adjuvant radiation therapy. The most frequently represented anatomic site for ocular and adnexal SCCs was the eyelid (28.7%). Coat color, breed, and the interaction of age and breed had a significant effect on tumor recurrence regardless of treatment type and anatomic location. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that ocular and adnexal SCCs treated with adjuvant radiation therapy had a significantly lower recurrence rate, compared with SCCs treated without adjuvant radiation therapy, independent of anatomic location.

Entities:  

Mesh:

Year:  2004        PMID: 15626225     DOI: 10.2460/javma.2004.225.1733

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Diagnostic Ophthalmology.

Authors:  Shayna Levitt; Stephanie Osinchuk; Lynne Sandmeyer
Journal:  Can Vet J       Date:  2020-07       Impact factor: 1.008

2.  Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses.

Authors:  Moriel H Singer-Berk; Kelly E Knickelbein; Zachary T Lounsberry; Margo Crausaz; Savanna Vig; Nikhil Joshi; Monica Britton; Matthew L Settles; Christopher M Reilly; Ellison Bentley; Catherine Nunnery; Ann Dwyer; Mary E Lassaline; Rebecca R Bellone
Journal:  Int J Genomics       Date:  2019-09-15       Impact factor: 2.326

3.  DDB2 Genetic Risk Factor for Ocular Squamous Cell Carcinoma Identified in Three Additional Horse Breeds.

Authors:  Margo Crausaz; Thomas Launois; Kathryn Smith-Fleming; Annette M McCoy; Kelly E Knickelbein; Rebecca R Bellone
Journal:  Genes (Basel)       Date:  2020-12-05       Impact factor: 4.096

4.  DNA methylation aging and transcriptomic studies in horses.

Authors:  Steve Horvath; Amin Haghani; Sichong Peng; Erin N Hales; Joseph A Zoller; Ken Raj; Brenda Larison; Todd R Robeck; Jessica L Petersen; Rebecca R Bellone; Carrie J Finno
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

5.  Electrochemotherapy for the treatment of cutaneous solid tumors in equids: A retrospective study.

Authors:  Enrico P Spugnini; Licia Scacco; Carlo Bolaffio; Alfonso Baldi
Journal:  Open Vet J       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.